Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer
2014 · Breast Cancer Research and Treatment · 96 citations
https://doi.org/10.1007/s10549-014-3253-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
216
Citations
4
h-index
4
i10-index
Betty Y Lung is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Chemotherapy-induced cardiotoxicity and mitigation & Cancer Treatment and Pharmacology. The author has an h-index of 4, co-authored 8 publications.
https://doi.org/10.1007/s10549-014-3253-7
https://doi.org/10.1634/theoncologist.2015-0125
Click to start Chat